Contact this trialFirst, we need to learn more about you.
Monoclonal Antibodies
BI 3706674 for Stomach and Esophageal Cancer
Recruiting1 awardPhase 1
Phoenix, Arizona
This trial is for adults with advanced stomach or oesophagus cancer who have no other treatment options. It tests a new drug, BI 3706674, taken as a tablet, to find an appropriate amount and see if it can shrink tumors by blocking their growth signals. Participants will have periodic health monitoring to track their health and any side effects.
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service.
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.
By clicking start, you agree to our
terms of service